Thymosin Alpha-1
Primary research interestImmune-modulation & inflammation research
Immune-modulating peptide approved in some jurisdictions for hepatitis B and other indications.
Immune research investigates peptides being studied for their potential effects on immune cell populations, immune signalling, and immune defence. This page reviews current scientific literature on peptide candidates for immunology and immune health research.
Last updated: 21 April 2026
Immune research investigates peptides modulating innate and adaptive immunity. Thymosin alpha-1 is studied for T-cell maturation and immune cell activation. KPV is examined for immune modulation and anti-inflammatory effects via melanocortin pathways. BPC-157 is investigated for immune tolerance and tissue-immune homeostasis. Research focuses on immune cell differentiation, cytokine signalling, and immune resilience.
Thymosin alpha-1 research shows robust T-cell activation in human studies, particularly in immunocompromised or aged populations. KPV demonstrates anti-inflammatory and immune-modulating effects in cell cultures and some human studies. BPC-157 animal studies suggest immune tolerance and reduced inflammatory responses in tissue injury contexts.
Most immune peptide research focuses on disease or deficiency contexts; healthy immune populations are underrepresented. Long-term immune effects and tolerance development are not well-characterised. Safety of immune enhancement in healthy individuals is debated. Comparative effectiveness versus established immunotherapy is sparse.
Thymosin alpha-1 has limited TGA pathways for specific immunodeficiency indications; immune enhancement in healthy populations is not approved. KPV and BPC-157 are not ARTG-registered. Medical practitioners cannot prescribe immune peptides for enhancement. Research-grade supply is legal for institutional research only.
Primary research interestImmune-modulation & inflammation research
Immune-modulating peptide approved in some jurisdictions for hepatitis B and other indications.
Primary research interestImmune-modulation & inflammation research
Tripeptide studied for anti-inflammatory pathways in research models.

Primary research interestTissue repair & recovery research
Broad healing peptide researched for tissue repair, injury recovery and gut health support.
Primary research interestCognitive performance & neuroprotection research
Peptide-enriched brain extract studied and used clinically for cognitive and neurological indications.